Proacta SA (PAC3)

Currency in PLN
1.650
+0.080(+5.10%)
Closed·

Proacta SA Company Profile

Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. The company offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; Digital Breast Cancer Unit, an innovative platform using advanced technologies to optimize the breast cancer treatment process; and Patient Portal, an innovative tool for monitoring health, managing medical data, and supporting the treatment process. It also provides AI/ML services and precise predictive models and software solutions. In addition, the company offers UX/UI design, web applications, mobile applications, DevOps / cloud services, dedicated solutions, and maintenance and development of existing IT systems services. The company was formerly known as Codeaddict S.A. and changed its name to Proacta S.A. in July 2023. Proacta S.A. was incorporated in 2015 and is based in Warsaw, Poland.

Employees
15
Market
Poland

Contact Information

Address
ul. Srebrna 16, Warsaw, 00-810, Poland
Phone
48 22 699 7132

Top Executives

Name
Title
Since
Age
Tomasz ChecinskiChairman of Supervisory Board2023-
Katarzyna GrzywackaVice Chair of the Supervisory Board2024-
Pawel DolinskiMember of the Supervisory Board--
Mariusz LukanowskiMember of the Supervisory Board--
Daniel NowocinMember of Supervisory Board2026-
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.